Significant improvements in treatment satisfaction (DTSQc) were observed at 6 months regardless of treatment modality (MDI or basal insulin only), diabetes type (T1D or T2D), or HCP practice type (specialist or nonspecialist), with a total mean (SD) score of 14.3 ± 5.1, <0.0001 (Fig. 2). This evidence concerns the gene INS and diabetes mellitus.